| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| ROTHBLATT MARTINE A | Chairperson & CEO, Director | C/O UNITED THERAPEUTICS CORPORATION, 1000 SPRING STREET, SILVER SPRING | /s/ John S. Hess, Jr. under Power of Attorney | 16 Mar 2026 | 0001106578 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | UTHR | Common Stock | Options Exercise | +9,500 | +7308% | $146.03* | 9,630 | 12 Mar 2026 | Direct | F1 | |
| transaction | UTHR | Common Stock | Sale | $340,582 | -640 | -6.6% | $532.16 | 8,990 | 12 Mar 2026 | Direct | F1, F2 |
| transaction | UTHR | Common Stock | Sale | $31,978 | -60 | -0.67% | $532.97 | 8,930 | 12 Mar 2026 | Direct | F1, F3 |
| transaction | UTHR | Common Stock | Sale | $276,053 | -516 | -5.8% | $534.99 | 8,414 | 16 Mar 2026 | Direct | F1, F4 |
| transaction | UTHR | Common Stock | Sale | $1,047,920 | -1,955 | -23% | $536.02 | 6,459 | 12 Mar 2026 | Direct | F1, F5 |
| transaction | UTHR | Common Stock | Sale | $951,266 | -1,772 | -27% | $536.83 | 4,687 | 12 Mar 2026 | Direct | F1, F6 |
| transaction | UTHR | Common Stock | Sale | $579,315 | -1,077 | -23% | $537.90 | 3,610 | 12 Mar 2026 | Direct | F1, F7 |
| transaction | UTHR | Common Stock | Sale | $388,038 | -720 | -20% | $538.94 | 2,890 | 12 Mar 2026 | Direct | F1, F8 |
| transaction | UTHR | Common Stock | Sale | $669,371 | -1,240 | -43% | $539.82 | 1,650 | 12 Mar 2026 | Direct | F1, F9 |
| transaction | UTHR | Common Stock | Sale | $216,524 | -400 | -24% | $541.31 | 1,250 | 12 Mar 2026 | Direct | F1, F10 |
| transaction | UTHR | Common Stock | Sale | $325,401 | -600 | -48% | $542.33 | 650 | 12 Mar 2026 | Direct | F1, F11 |
| transaction | UTHR | Common Stock | Sale | $193,388 | -356 | -55% | $543.22 | 294 | 12 Mar 2026 | Direct | F1, F12 |
| transaction | UTHR | Common Stock | Sale | $89,312 | -164 | -56% | $544.58 | 130 | 12 Mar 2026 | Direct | F1, F13 |
| holding | UTHR | Common Stock | 166 | 12 Mar 2026 | by Spouse | ||||||
| holding | UTHR | Common Stock | 324,518 | 12 Mar 2026 | by Trust | F14 | |||||
| holding | UTHR | Common Stock | 258,117 | 12 Mar 2026 | by Trust | F15 | |||||
| holding | UTHR | Common Stock | 45,596 | 12 Mar 2026 | by Trust | F16 | |||||
| holding | UTHR | Common Stock | 10,962 | 12 Mar 2026 | by Trust | F17 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | UTHR | Stock Option | Options Exercise | -9,500 | -5.8% | $0.000000* | 154,500 | 12 Mar 2026 | Common Stock | 9,500 | $146.03 | Direct | F1 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 17, 2027; or (b) December 31, 2026. |
| F2 | This transaction was executed in multiple trades at prices ranging from $531.94 to $532.59. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected |
| F3 | This transaction was executed in multiple trades at prices ranging from $532.94 to $532.99. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected |
| F4 | This transaction was executed in multiple trades at prices ranging from $534.42 to $535.39. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected |
| F5 | This transaction was executed in multiple trades at prices ranging from $535.45 to $536.44. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected |
| F6 | This transaction was executed in multiple trades at prices ranging from $536.45 to $537.44. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected |
| F7 | This transaction was executed in multiple trades at prices ranging from $537.47 to $538.43. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected |
| F8 | This transaction was executed in multiple trades at prices ranging from $538.48 to $539.45. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected |
| F9 | This transaction was executed in multiple trades at prices ranging from $539.48 to $540.45. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected |
| F10 | This transaction was executed in multiple trades at prices ranging from $540.73 to $541.69. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected |
| F11 | This transaction was executed in multiple trades at prices ranging from $541.86 to $542.85. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected |
| F12 | This transaction was executed in multiple trades at prices ranging from $542.88 to $543.86. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected |
| F13 | This transaction was executed in multiple trades at prices ranging from $543.90 to $544.80. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected |
| F14 | Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries. |
| F15 | Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke. |
| F16 | Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries. |
| F17 | Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke. |